Literature DB >> 26391409

Pregnancy complications and cardiovascular disease death: 50-year follow-up of the Child Health and Development Studies pregnancy cohort.

Piera M Cirillo1, Barbara A Cohn2.   

Abstract

BACKGROUND: Few studies have investigated the combination of pregnancy complications that predict risk for cardiovascular disease (CVD) death and how risk changes with age. This report presents a comprehensive investigation of the relation of the occurrence of multiple pregnancy complications to CVD death over 5 decades in a large pregnancy cohort. METHODS AND
RESULTS: We examined pregnancy events (1959-1967) and CVD death through 2011 in 14 062 women from the Child Health and Development Studies. CVD death was determined by linkage to California Vital Statistics and National Death Index. Women were a median age of 26 years at enrollment and 66 years in 2011. Preexisting hypertension (hazard ratio, 3.5; 95% confidence interval, 2.4-5.1); glycosuria (hazard ratio, 4.2; confidence interval, 1.3-13.1); late-onset preeclampsia (after week 34, hazard ratio, 2.0; confidence interval, 1.2-3.5); and hemoglobin decline over the second and third trimesters (hazard ratio, 1.7; confidence interval, 1.2-2.7) predicted CVD death. Delivery of a small-for-gestation or preterm infant and early-onset preeclampsia (by week 34) significantly predicted premature CVD death (P<0.05 for age dependence). Preterm birth combined with hemorrhage, gestational hypertension, or preexisting hypertension identified women with a 4- to 7-fold increased risk of CVD death. Preeclampsia in combination with preexisting hypertension conferred a significant nearly 6-fold risk in comparison with a 4-fold risk for preexisting hypertension alone.
CONCLUSIONS: We observed combinations of pregnancy complications that predict high risk of death and 2 new risk markers, glycosuria and hemoglobin decline. Obstetricians serve as primary care physicians for many young women and can readily use these complications to identify high-risk women to implement early prevention.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  cardiovascular diseases; cohort studies; hypertension; mortality; preeclampsia; pregnancy; preterm birth

Mesh:

Substances:

Year:  2015        PMID: 26391409     DOI: 10.1161/CIRCULATIONAHA.113.003901

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  57 in total

1.  In utero DDT exposure and breast density in early menopause by maternal history of breast cancer.

Authors:  Jasmine A McDonald; Piera M Cirillo; Parisa Tehranifar; Nickilou Y Krigbaum; Natalie J Engmann; Barbara A Cohn; Mary Beth Terry
Journal:  Reprod Toxicol       Date:  2019-08-14       Impact factor: 3.143

Review 2.  Vascular Dysfunction in Mother and Offspring During Preeclampsia: Contributions from Latin-American Countries.

Authors:  Fernanda Regina Giachini; Carlos Galaviz-Hernandez; Alicia E Damiano; Marta Viana; Angela Cadavid; Patricia Asturizaga; Enrique Teran; Sonia Clapes; Martin Alcala; Julio Bueno; María Calderón-Domínguez; María P Ramos; Victor Vitorino Lima; Martha Sosa-Macias; Nora Martinez; James M Roberts; Carlos Escudero
Journal:  Curr Hypertens Rep       Date:  2017-10-06       Impact factor: 5.369

Review 3.  Low molecular weight heparin for the prevention of severe preeclampsia: where next?

Authors:  Kelsey McLaughlin; Ralph R Scholten; John D Parker; Enrico Ferrazzi; John C P Kingdom
Journal:  Br J Clin Pharmacol       Date:  2018-01-29       Impact factor: 4.335

4.  Putting the "M" back in maternal-fetal medicine: A 5-year report card on a collaborative effort to address maternal morbidity and mortality in the United States.

Authors:  Mary E D'Alton; Alexander M Friedman; Peter S Bernstein; Haywood L Brown; William M Callaghan; Steven L Clark; William A Grobman; Sarah J Kilpatrick; Daniel F O'Keeffe; Douglas M Montgomery; Sindhu K Srinivas; George D Wendel; Katharine D Wenstrom; Michael R Foley
Journal:  Am J Obstet Gynecol       Date:  2019-03-05       Impact factor: 8.661

5.  Estimated Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on Reproductive-Aged Women.

Authors:  Matthew L Topel; Erin M Duncan; Iris Krishna; Martina L Badell; Viola Vaccarino; Arshed A Quyyumi
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

6.  Pregnancy complications and later vascular ultrasound measures: A cohort study.

Authors:  Emily W Harville; Markus Juonala; Jorma S A Viikari; Mika Kähönen; Olli T Raitakari
Journal:  Pregnancy Hypertens       Date:  2017-08-04       Impact factor: 2.899

7.  Reproductive history and physical functioning in midlife: The Bogalusa Heart Study.

Authors:  Emily W Harville; Wei Chen; Jack Guralnik; Lydia A Bazzano
Journal:  Maturitas       Date:  2017-12-08       Impact factor: 4.342

8.  ELABELA plasma concentrations are increased in women with late-onset preeclampsia.

Authors:  Bogdan Panaitescu; Roberto Romero; Nardhy Gomez-Lopez; Percy Pacora; Offer Erez; Felipe Vadillo-Ortega; Lami Yeo; Sonia S Hassan; Chaur-Dong Hsu
Journal:  J Matern Fetal Neonatal Med       Date:  2018-07-22

9.  Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy.

Authors:  Lauren H Theilen; Huong Meeks; Alison Fraser; M Sean Esplin; Ken R Smith; Michael W Varner
Journal:  Am J Obstet Gynecol       Date:  2018-04-07       Impact factor: 8.661

10.  Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.

Authors:  Frank T Spradley; Adelene Y Tan; Woo S Joo; Garrett Daniels; Paul Kussie; S Ananth Karumanchi; Joey P Granger
Journal:  Hypertension       Date:  2016-02-01       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.